首页> 外文期刊>Nature Communications >IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling
【24h】

IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling

机译:T细胞受体IMGT克隆型多样性和下一代库免疫谱的IMGT / HighV QUEST范例

获取原文
           

摘要

T cell repertoire diversity and clonotype follow-up in vaccination, cancer, infectious and immune diseases represent a major challenge owing to the enormous complexity of the data generated. Here we describe a next generation methodology, which combines 5′RACE PCR, 454 sequencing and, for analysis, IMGT, the international ImMunoGeneTics information system (IMGT), IMGT/HighV-QUEST web portal and IMGT-ONTOLOGY concepts. The approach is validated in a human case study of T cell receptor beta ( TRB ) repertoire, by chronologically tracking the effects of influenza vaccination on conventional and regulatory T cell subpopulations. The IMGT/HighV-QUEST paradigm defines standards for genotype/haplotype analysis and characterization of IMGT clonotypes for clonal diversity and expression and achieves a degree of resolution for next generation sequencing verifiable by the user at the sequence level, while providing a normalized reference immunoprofile for human TRB .
机译:疫苗,癌症,传染性和免疫性疾病中的T细胞库多样性和克隆型随访是一项主要挑战,因为所产生数据的复杂性很高。在这里,我们描述了下一代方法,该方法结合了5'RACE PCR,454测序以及IMGT,国际ImMunoGeneTics信息系统(IMGT),IMGT / HighV-QUEST网站门户和IMGT-ONTOLOGY概念进行分析。通过按时间顺序跟踪流感疫苗接种对常规和调节性T细胞亚群的影响,该方法已在T细胞受体beta(TRB)曲目的人类案例研究中得到验证。 IMGT / HighV-QUEST范式定义了基因型/单倍型分析的标准以及IMGT克隆型的特征,以进行克隆多样性和表达,并为用户可在序列水平上验证的下一代测序达到一定程度的分辨率,同时为人类TRB。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号